Global Noninvasive Cancer Diagnostics Market Growth (Status and Outlook) 2022-2028
- LP 4852822
- 100 Pages
- February 2022
- Medical Devices
The United States Noninvasive Cancer Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Noninvasive Cancer Diagnostics market, reaching US$ million by the year 2028. As for the Europe Noninvasive Cancer Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Noninvasive Cancer Diagnostics players cover Precision Therapeutics, Inc. (U.S.), A&G Pharmaceutical, Inc. (U.S.), Affymetrix Inc. (U.S.), and AVIVA Biosciences Corporation (U.S.), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Noninvasive Cancer Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Solid Tumors
Blood Cancer
Lung Cancer
Breast Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Precision Therapeutics, Inc. (U.S.)
A&G Pharmaceutical, Inc. (U.S.)
Affymetrix Inc. (U.S.)
AVIVA Biosciences Corporation (U.S.)
BIOVIEW Inc. (U.S.)
Laboratory Corporation of America Holdings (LabCorp) (U.S.)
Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
Digene Corporation (U.S.)
Gen-Probe Incorporated (U.S.)
IVDiagnostics, Inc. (U.S.)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Noninvasive Cancer Diagnostics Market Size 2017-2028
2.1.2 Noninvasive Cancer Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Noninvasive Cancer Diagnostics Segment by Type
2.2.1 Clinical Chemistry
2.2.2 Immunochemistry/Immunoassay
2.2.3 Molecular Diagnostics
2.2.4 Others
2.3 Noninvasive Cancer Diagnostics Market Size by Type
2.3.1 Noninvasive Cancer Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Noninvasive Cancer Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Noninvasive Cancer Diagnostics Segment by Application
2.4.1 Solid Tumors
2.4.2 Blood Cancer
2.4.3 Lung Cancer
2.4.4 Breast Cancer
2.4.5 Others
2.5 Noninvasive Cancer Diagnostics Market Size by Application
2.5.1 Noninvasive Cancer Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Noninvasive Cancer Diagnostics Market Size Market Share by Application (2017-2022)
3 Noninvasive Cancer Diagnostics Market Size by Player
3.1 Noninvasive Cancer Diagnostics Market Size Market Share by Players
3.1.1 Global Noninvasive Cancer Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Noninvasive Cancer Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Noninvasive Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Noninvasive Cancer Diagnostics by Regions
4.1 Noninvasive Cancer Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Noninvasive Cancer Diagnostics Market Size Growth (2017-2022)
4.3 APAC Noninvasive Cancer Diagnostics Market Size Growth (2017-2022)
4.4 Europe Noninvasive Cancer Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Noninvasive Cancer Diagnostics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Noninvasive Cancer Diagnostics Market Size by Country (2017-2022)
5.2 Americas Noninvasive Cancer Diagnostics Market Size by Type (2017-2022)
5.3 Americas Noninvasive Cancer Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Noninvasive Cancer Diagnostics Market Size by Region (2017-2022)
6.2 APAC Noninvasive Cancer Diagnostics Market Size by Type (2017-2022)
6.3 APAC Noninvasive Cancer Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Noninvasive Cancer Diagnostics by Country (2017-2022)
7.2 Europe Noninvasive Cancer Diagnostics Market Size by Type (2017-2022)
7.3 Europe Noninvasive Cancer Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Noninvasive Cancer Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Noninvasive Cancer Diagnostics Market Forecast
10.1 Global Noninvasive Cancer Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Noninvasive Cancer Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Noninvasive Cancer Diagnostics Forecast
10.1.3 APAC Noninvasive Cancer Diagnostics Forecast
10.1.4 Europe Noninvasive Cancer Diagnostics Forecast
10.1.5 Middle East & Africa Noninvasive Cancer Diagnostics Forecast
10.2 Americas Noninvasive Cancer Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Noninvasive Cancer Diagnostics Market Forecast
10.2.2 Canada Noninvasive Cancer Diagnostics Market Forecast
10.2.3 Mexico Noninvasive Cancer Diagnostics Market Forecast
10.2.4 Brazil Noninvasive Cancer Diagnostics Market Forecast
10.3 APAC Noninvasive Cancer Diagnostics Forecast by Region (2023-2028)
10.3.1 China Noninvasive Cancer Diagnostics Market Forecast
10.3.2 Japan Noninvasive Cancer Diagnostics Market Forecast
10.3.3 Korea Noninvasive Cancer Diagnostics Market Forecast
10.3.4 Southeast Asia Noninvasive Cancer Diagnostics Market Forecast
10.3.5 India Noninvasive Cancer Diagnostics Market Forecast
10.3.6 Australia Noninvasive Cancer Diagnostics Market Forecast
10.4 Europe Noninvasive Cancer Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Noninvasive Cancer Diagnostics Market Forecast
10.4.2 France Noninvasive Cancer Diagnostics Market Forecast
10.4.3 UK Noninvasive Cancer Diagnostics Market Forecast
10.4.4 Italy Noninvasive Cancer Diagnostics Market Forecast
10.4.5 Russia Noninvasive Cancer Diagnostics Market Forecast
10.5 Middle East & Africa Noninvasive Cancer Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Noninvasive Cancer Diagnostics Market Forecast
10.5.2 South Africa Noninvasive Cancer Diagnostics Market Forecast
10.5.3 Israel Noninvasive Cancer Diagnostics Market Forecast
10.5.4 Turkey Noninvasive Cancer Diagnostics Market Forecast
10.5.5 GCC Countries Noninvasive Cancer Diagnostics Market Forecast
10.6 Global Noninvasive Cancer Diagnostics Forecast by Type (2023-2028)
10.7 Global Noninvasive Cancer Diagnostics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Precision Therapeutics, Inc. (U.S.)
11.1.1 Precision Therapeutics, Inc. (U.S.) Company Information
11.1.2 Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product Offered
11.1.3 Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Precision Therapeutics, Inc. (U.S.) Main Business Overview
11.1.5 Precision Therapeutics, Inc. (U.S.) Latest Developments
11.2 A&G Pharmaceutical, Inc. (U.S.)
11.2.1 A&G Pharmaceutical, Inc. (U.S.) Company Information
11.2.2 A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Product Offered
11.2.3 A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 A&G Pharmaceutical, Inc. (U.S.) Main Business Overview
11.2.5 A&G Pharmaceutical, Inc. (U.S.) Latest Developments
11.3 Affymetrix Inc. (U.S.)
11.3.1 Affymetrix Inc. (U.S.) Company Information
11.3.2 Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Product Offered
11.3.3 Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Affymetrix Inc. (U.S.) Main Business Overview
11.3.5 Affymetrix Inc. (U.S.) Latest Developments
11.4 AVIVA Biosciences Corporation (U.S.)
11.4.1 AVIVA Biosciences Corporation (U.S.) Company Information
11.4.2 AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Product Offered
11.4.3 AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 AVIVA Biosciences Corporation (U.S.) Main Business Overview
11.4.5 AVIVA Biosciences Corporation (U.S.) Latest Developments
11.5 BIOVIEW Inc. (U.S.)
11.5.1 BIOVIEW Inc. (U.S.) Company Information
11.5.2 BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Product Offered
11.5.3 BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 BIOVIEW Inc. (U.S.) Main Business Overview
11.5.5 BIOVIEW Inc. (U.S.) Latest Developments
11.6 Laboratory Corporation of America Holdings (LabCorp) (U.S.)
11.6.1 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Company Information
11.6.2 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Product Offered
11.6.3 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Main Business Overview
11.6.5 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Latest Developments
11.7 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
11.7.1 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Company Information
11.7.2 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Product Offered
11.7.3 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Main Business Overview
11.7.5 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Latest Developments
11.8 Digene Corporation (U.S.)
11.8.1 Digene Corporation (U.S.) Company Information
11.8.2 Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Product Offered
11.8.3 Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Digene Corporation (U.S.) Main Business Overview
11.8.5 Digene Corporation (U.S.) Latest Developments
11.9 Gen-Probe Incorporated (U.S.)
11.9.1 Gen-Probe Incorporated (U.S.) Company Information
11.9.2 Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Product Offered
11.9.3 Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Gen-Probe Incorporated (U.S.) Main Business Overview
11.9.5 Gen-Probe Incorporated (U.S.) Latest Developments
11.10 IVDiagnostics, Inc. (U.S.)
11.10.1 IVDiagnostics, Inc. (U.S.) Company Information
11.10.2 IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product Offered
11.10.3 IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 IVDiagnostics, Inc. (U.S.) Main Business Overview
11.10.5 IVDiagnostics, Inc. (U.S.) Latest Developments
12 Research Findings and Conclusion
Table 1. Noninvasive Cancer Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Clinical Chemistry
Table 3. Major Players of Immunochemistry/Immunoassay
Table 4. Major Players of Molecular Diagnostics
Table 5. Major Players of Others
Table 6. Noninvasive Cancer Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Noninvasive Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Noninvasive Cancer Diagnostics Market Size Market Share by Type (2017-2022)
Table 9. Noninvasive Cancer Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Noninvasive Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Noninvasive Cancer Diagnostics Market Size Market Share by Application (2017-2022)
Table 12. Global Noninvasive Cancer Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Noninvasive Cancer Diagnostics Revenue Market Share by Player (2020-2022)
Table 14. Noninvasive Cancer Diagnostics Key Players Head office and Products Offered
Table 15. Noninvasive Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Noninvasive Cancer Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Noninvasive Cancer Diagnostics Market Size Market Share by Regions (2017-2022)
Table 20. Americas Noninvasive Cancer Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Noninvasive Cancer Diagnostics Market Size Market Share by Country (2017-2022)
Table 22. Americas Noninvasive Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Noninvasive Cancer Diagnostics Market Size Market Share by Type (2017-2022)
Table 24. Americas Noninvasive Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Noninvasive Cancer Diagnostics Market Size Market Share by Application (2017-2022)
Table 26. APAC Noninvasive Cancer Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Noninvasive Cancer Diagnostics Market Size Market Share by Region (2017-2022)
Table 28. APAC Noninvasive Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Noninvasive Cancer Diagnostics Market Size Market Share by Type (2017-2022)
Table 30. APAC Noninvasive Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Noninvasive Cancer Diagnostics Market Size Market Share by Application (2017-2022)
Table 32. Europe Noninvasive Cancer Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Noninvasive Cancer Diagnostics Market Size Market Share by Country (2017-2022)
Table 34. Europe Noninvasive Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Noninvasive Cancer Diagnostics Market Size Market Share by Type (2017-2022)
Table 36. Europe Noninvasive Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Noninvasive Cancer Diagnostics Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Noninvasive Cancer Diagnostics Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Noninvasive Cancer Diagnostics Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Noninvasive Cancer Diagnostics Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Noninvasive Cancer Diagnostics
Table 45. Key Market Challenges & Risks of Noninvasive Cancer Diagnostics
Table 46. Key Industry Trends of Noninvasive Cancer Diagnostics
Table 47. Global Noninvasive Cancer Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Noninvasive Cancer Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Noninvasive Cancer Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Noninvasive Cancer Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Noninvasive Cancer Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Noninvasive Cancer Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 53. Precision Therapeutics, Inc. (U.S.) Details, Company Type, Noninvasive Cancer Diagnostics Area Served and Its Competitors
Table 54. Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product Offered
Table 55. Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Precision Therapeutics, Inc. (U.S.) Main Business
Table 57. Precision Therapeutics, Inc. (U.S.) Latest Developments
Table 58. A&G Pharmaceutical, Inc. (U.S.) Details, Company Type, Noninvasive Cancer Diagnostics Area Served and Its Competitors
Table 59. A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Product Offered
Table 60. A&G Pharmaceutical, Inc. (U.S.) Main Business
Table 61. A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. A&G Pharmaceutical, Inc. (U.S.) Latest Developments
Table 63. Affymetrix Inc. (U.S.) Details, Company Type, Noninvasive Cancer Diagnostics Area Served and Its Competitors
Table 64. Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Product Offered
Table 65. Affymetrix Inc. (U.S.) Main Business
Table 66. Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Affymetrix Inc. (U.S.) Latest Developments
Table 68. AVIVA Biosciences Corporation (U.S.) Details, Company Type, Noninvasive Cancer Diagnostics Area Served and Its Competitors
Table 69. AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Product Offered
Table 70. AVIVA Biosciences Corporation (U.S.) Main Business
Table 71. AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. AVIVA Biosciences Corporation (U.S.) Latest Developments
Table 73. BIOVIEW Inc. (U.S.) Details, Company Type, Noninvasive Cancer Diagnostics Area Served and Its Competitors
Table 74. BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Product Offered
Table 75. BIOVIEW Inc. (U.S.) Main Business
Table 76. BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. BIOVIEW Inc. (U.S.) Latest Developments
Table 78. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Details, Company Type, Noninvasive Cancer Diagnostics Area Served and Its Competitors
Table 79. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Product Offered
Table 80. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Main Business
Table 81. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Latest Developments
Table 83. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Details, Company Type, Noninvasive Cancer Diagnostics Area Served and Its Competitors
Table 84. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Product Offered
Table 85. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Main Business
Table 86. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Latest Developments
Table 88. Digene Corporation (U.S.) Details, Company Type, Noninvasive Cancer Diagnostics Area Served and Its Competitors
Table 89. Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Product Offered
Table 90. Digene Corporation (U.S.) Main Business
Table 91. Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Digene Corporation (U.S.) Latest Developments
Table 93. Gen-Probe Incorporated (U.S.) Details, Company Type, Noninvasive Cancer Diagnostics Area Served and Its Competitors
Table 94. Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Product Offered
Table 95. Gen-Probe Incorporated (U.S.) Main Business
Table 96. Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Gen-Probe Incorporated (U.S.) Latest Developments
Table 98. IVDiagnostics, Inc. (U.S.) Details, Company Type, Noninvasive Cancer Diagnostics Area Served and Its Competitors
Table 99. IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product Offered
Table 100. IVDiagnostics, Inc. (U.S.) Main Business
Table 101. IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. IVDiagnostics, Inc. (U.S.) Latest Developments
List of Figures
Figure 1. Noninvasive Cancer Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Noninvasive Cancer Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Noninvasive Cancer Diagnostics Market Size Market Share by Type in 2021
Figure 7. Noninvasive Cancer Diagnostics in Solid Tumors
Figure 8. Global Noninvasive Cancer Diagnostics Market: Solid Tumors (2017-2022) & ($ Millions)
Figure 9. Noninvasive Cancer Diagnostics in Blood Cancer
Figure 10. Global Noninvasive Cancer Diagnostics Market: Blood Cancer (2017-2022) & ($ Millions)
Figure 11. Noninvasive Cancer Diagnostics in Lung Cancer
Figure 12. Global Noninvasive Cancer Diagnostics Market: Lung Cancer (2017-2022) & ($ Millions)
Figure 13. Noninvasive Cancer Diagnostics in Breast Cancer
Figure 14. Global Noninvasive Cancer Diagnostics Market: Breast Cancer (2017-2022) & ($ Millions)
Figure 15. Noninvasive Cancer Diagnostics in Others
Figure 16. Global Noninvasive Cancer Diagnostics Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Noninvasive Cancer Diagnostics Market Size Market Share by Application in 2021
Figure 18. Global Noninvasive Cancer Diagnostics Revenue Market Share by Player in 2021
Figure 19. Global Noninvasive Cancer Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Noninvasive Cancer Diagnostics Market Size 2017-2022 ($ Millions)
Figure 21. APAC Noninvasive Cancer Diagnostics Market Size 2017-2022 ($ Millions)
Figure 22. Europe Noninvasive Cancer Diagnostics Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Noninvasive Cancer Diagnostics Market Size 2017-2022 ($ Millions)
Figure 24. Americas Noninvasive Cancer Diagnostics Value Market Share by Country in 2021
Figure 25. Americas Noninvasive Cancer Diagnostics Consumption Market Share by Type in 2021
Figure 26. Americas Noninvasive Cancer Diagnostics Market Size Market Share by Application in 2021
Figure 27. United States Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Noninvasive Cancer Diagnostics Market Size Market Share by Region in 2021
Figure 32. APAC Noninvasive Cancer Diagnostics Market Size Market Share by Application in 2021
Figure 33. China Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Noninvasive Cancer Diagnostics Market Size Market Share by Country in 2021
Figure 40. Europe Noninvasive Cancer Diagnostics Market Size Market Share by Type in 2021
Figure 41. Europe Noninvasive Cancer Diagnostics Market Size Market Share by Application in 2021
Figure 42. Germany Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Noninvasive Cancer Diagnostics Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Noninvasive Cancer Diagnostics Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Noninvasive Cancer Diagnostics Market Size Market Share by Application in 2021
Figure 50. Egypt Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Noninvasive Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 56. APAC Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 57. Europe Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 59. United States Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 60. Canada Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 63. China Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 64. Japan Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 65. Korea Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 67. India Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 68. Australia Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 69. Germany Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 70. France Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 71. UK Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 72. Italy Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 73. Russia Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 74. Spain Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 77. Israel Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Noninvasive Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
